A detailed history of Welch Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Welch Group, LLC holds 4,641 shares of BSX stock, worth $448,784. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,641
Previous 4,482 3.55%
Holding current value
$448,784
Previous $452,000 10.18%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 25, 2025

BUY
$89.7 - $107.41 $14,262 - $17,078
159 Added 3.55%
4,641 $498,000
Q1 2025

Apr 07, 2025

SELL
$89.38 - $106.18 $5,094 - $6,052
-57 Reduced 1.26%
4,482 $452,000
Q4 2024

Jan 24, 2025

BUY
$83.62 - $91.5 $157,372 - $172,203
1,882 Added 70.83%
4,539 $405,000
Q2 2024

Jul 17, 2024

BUY
$67.33 - $77.71 $178,895 - $206,475
2,657 New
2,657 $204,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $138B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Welch Group, LLC Portfolio

Follow Welch Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch Group, LLC with notifications on news.